Inventor · disambiguated record
Florian Colbatzky
Also filed as: COLBATZKY FLORIAN · COLBATZKY FLORIAN ANDREAS
8 granted patents·7 pending applications·246 citations·filing 2003–2023
89Inventor score
Top patents by PatentIndex Score
15 records- 0197US7750152B2Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositions and processes of making the sameBOEHRINGER INGELHEIM PHARMA·Filed 2007·Granted Jul 6, 2010·47 cites·12 claims
- 0297US6861422B2Dihydropteridinones, processes for preparing them and their use as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted Mar 1, 2005·115 cites·8 claims
- 0396US8003786B2Dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2010·Granted Aug 23, 2011·34 cites·1 claims
- 0496US7786299B2Methods for treating diseases or conditions using dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Aug 31, 2010·19 cites·14 claims
- 0588US7989474B2Use of Lck inhibitors for treatment of immunologic diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2008·Granted Aug 2, 2011·14 cites·2 claims
- 0685US7189743B2Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amideBOEHRINGER INGELHEIM PHARMA·Filed 2005·Granted Mar 13, 2007·7 cites·18 claims
- 0778US6900229B2Prodrugs of 1-methyl-2-(4-amidinophenylaminomethyl)-benzimidazol-5-yl-carboxylic acid-(N-2-pyridyl-N-2-hydroxycarbonylethyl)-amideBOEHRINGER INGELHEIM PHARMA·Filed 2003·Granted May 31, 2005·10 cites·8 claims
- 0866US2024058264A1Pharmaceutical formulations of nintedanib for intraocular useBOEHRINGER INGELHEIM INT·Filed 2023·Application pending·0 cites
- 0961US2009306104A1Use of Lck inhibitors for treatment of immunologic diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2009·Application pending·0 cites
- 1060US2005014760A1Methods of treating diseases or conditions using dihydropteridinone compoundsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 1159US2005014761A1Intermediate compounds for making dihydropteridinones useful as pharmaceutical compositionsBOEHRINGER INGELHEIM PHARMA·Filed 2004·Application pending·0 cites
- 1255US2007099918A1Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH) / prostatic hypertrophyBOEHRINGER INGELHEIM PHARMA·Filed 2006·Application pending·0 cites
- 1353US2004204458A1Use of Lck inhibitors for treatment of immunologic diseasesBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 1449US2003225079A1Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophyBOEHRINGER INGELHEIM PHARMA·Filed 2003·Application pending·0 cites
- 1528US8431585B2Use of inhibitors of the EGFR-mediated signal transduction for the treatment of benign prostatic hyperplasia (BPH)/prostatic hypertrophySINGER THOMAS·Filed 2010·Granted Apr 30, 2013·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Florian Colbatzky files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →